Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. Its lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. The company also develops e-InVivo, a sensor implant to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, it develops UriControl, a remote controlled implant to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and MS patients to urinate on demand using the wireless platform. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica AG is a subsidiary of Implantica MediSwiss.
Implantica Dividend Announcement
• Implantica does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Implantica dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.
Implantica Dividend History
Implantica Dividend Yield
Implantica current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Implantica stock? Use our calculator to estimate your expected dividend yield:
Implantica Financial Ratios
Implantica Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Implantica stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.